PBS

‘Breakthough’ as first targeted lupus drug hits PBS

Dermatology patients to benefit from PBAC outcomes

PBS tapentadol dispensing declines

Melanoma drug newly listed on PBS

PBS cuts etanercept red tape

Almost 5m Aussies to benefit from Shingrix listing

Shingrix to be funded from 1 November

Shingrix greenlit for immune compromised over-18s
